Cargando…
The Average Time Gap Between CA-125 Tumor Marker Elevation and Confirmation of Recurrence in Epithelial Ovarian Cancer Patients at Princess Noorah Oncology Center, Jeddah, Saudi Arabia
The monitoring of the tumor marker cancer antigen 125 (CA-125) is commonly used as a part of epithelial ovarian cancer monitoring for recurrence. This study seeks to calculate the average time between CA-125 elevation above 35 IU/mL and evidence of recurrence through any currently accepted modality...
Autores principales: | Moharrag, Ali, Yonbawi, Faisal, Bashawieh, Hussam H, Basabrain, Ahmed, Al-Jifree, Hatim M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462651/ https://www.ncbi.nlm.nih.gov/pubmed/32884874 http://dx.doi.org/10.7759/cureus.9518 |
Ejemplares similares
-
Common Complications of Cesarean Section During the Year 2017 in King Abdulaziz Medical City, Jeddah, Saudi Arabia
por: Aljohani, Aljoharah A, et al.
Publicado: (2021) -
Demographic features, clinical characteristics, and prognostic factors of non-epithelial ovarian tumors at Princess Noorah Oncology Center, National Guard Hospital, Jeddah, Saudi Arabia
por: Balkhy, Atheel L., et al.
Publicado: (2022) -
The Rates of Cesarean Section Deliveries According to Robson Classification System During the Year of 2018 Among Patients in King Abdul-Aziz Medical City, Jeddah, Saudi Arabia
por: Alsulami, Shaymaa M, et al.
Publicado: (2020) -
Prevalence of Anemia Among Gynecologic Cancer Patients Who Received Chemotherapy, Radiotherapy, or a Combination of Both at King Abdulaziz Medical City, Jeddah
por: Alghamdi, Atheer H, et al.
Publicado: (2021) -
Uterine Malignancy: Pathological Pattern and Changing Incidence in a Teaching Hospital in Jeddah, Saudi Arabia
por: Turkistani, Abdulrahim K, et al.
Publicado: (2023)